Anticoagulation Certificate Training Program

AzPA’s Anticoagulation Certificate Program – Hosted by California Pharmacists Association

The Anticoagulation certificate program provides pharmacists with the basic knowledge and skills necessary to care for patients taking anticoagulation therapies. With expanded use of anticoagulant agents, the number of patients receiving these drugs has increased dramatically. Safe and effective anticoagulation must include a number of key components to avoid complications. These include careful patient assessment, an understanding of the clotting cascade and mechanisms of action of anticoagulant therapies, a detailed focus on factors which influence therapy and knowledge of current guidelines.

Sign up early!
This certificate training program has 14 hours of home self-study to be completed prior to the live training.

How to Register & What to Expect:

Step 1: Click on a date below to register for the date/location you prefer
Step 2: Login (or create an account if you don’t have one) and pay for the course
Step 3: Watch for an email confirmation with instructions on how to access the home study materials
Step 4: Access your home study materials and complete ALL required items BEFORE the live training program
Step 5: Attend the live training program & receive instructions on accessing the final exam
Step 6: Complete/pass the final exam within one week of the live training program to receive your certificate

Upcoming Events

There are no upcoming events at this time.

Registration Fees


Early Rate

(rec’d 4 weeks prior to course) 

Regular Rate

(rec’d 2 weeks prior to the course)
CPhA Member   $369  $419
Non-Member*      $639  $689
CPhA Student Pharmacist  $289  $339
Non-Member Student Pharmacist  $319  $369

*Non-member pharmacists: If you join CPhA today, you will receive $100 off of your membership! To take advantage of the new member savings, please contact us at (916) 779-1400.

**Registration fees are non-refundable and non-transferrable under any circumstances. Please be advised that this program is subject to postponement or cancellation if the required minimum number of registrants is not met at least 10 days prior to the program.**

 

Part 1: Home-Study Module (14 hours)

The didactic home study will consist of:

  • Reading selected monographs relating to the 2012 ACCP Chest Evidence-Based Guidelines,
  • View the 2 videos
  • Completing a study guide with assessment questions, and
  • Complete an online assessment test. Note: A score of at least 70% or better is needed in order to qualify as passed. 

Upon registration, a link to the home study content will be emailed to the email address indicated on registration. The self-study exam must be completed prior to the live session. As you check in to the live session we will confirm your completion of the study guide. Pharmacists will receive CPE credits of a total of 14 hours or 1.4 CEUs for the home study portion of this program.

Learning Objectives
  • Differentiate the pharmacology and pharmacokinetics of UFH, LMWH, warfarin, direct thrombin inhibitors, and factor XA inhibitors
  • Define the current recommendations for indication-specific intensity and duration of anticoagulation treatment
  • Recognize strategies used to manage hemorrhagic complications and HIT associated with anticoagulant therapy
  • Identify appropriate methods to manage antithrombotic therapy during the perioperative time period

Part 2: Live Training Module (8 Hours)

The live program involves 8 hours (0.80 CEUs) of both lecture and simulation training. Participants will focus on the pathophysiology of thrombosis, receive an overview of ACCP Guidelines, discuss indications for anticoagulation therapy, warfarin dosing and monitoring, management of the over-anticoagulated patient and patients requiring procedure management, patient education, and patient interviewing and assessment. Participants will also learn about point-of care monitoring devices, and practice assessing patients through the use of patient cases. At the conclusion of the live program an online, final exam must be completed with a score of at least 70% correct responses in order to receive a certificate of completion. Pharmacists will receive a total of 8 hours or 0.8 CEUs for completion of this component. 

Learning Objectives
  • Review pathophysiology of thrombosis
  • Describe the difference in mechanism of action between the new and old antithrombotic therapies
  • Describe the indications for anticoagulation therapy
  • Review current treatment guidelines
  • Evaluate the initiation and dosing of warfarin
  • Determine factors influencing dosing of warfarin and the appropriate management of out-of-range INRs
  • Develop assessment tools which account for variables impacting warfarin intensity and dosing
  • Compare and contrast available point of care devices for anticoagulation therapies and demonstrate correct patient care procedures for testing
  • Evaluate ‘bridging” therapies for anticoagulation management
  • Practice assessing patients on anticoagulation therapies through the use of patient cases

Anticoagulation Certificate

In order to receive your certificate of completion, you must successfully complete both parts of the Anticoagulation Certificate Program.

Topics Covered

Credit Hours

The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The application-based self-study learning portion and live training seminar of the Anticoagulation Certificate Program is approved for 22 hours (2.2 CEUs) of continuing pharmacy education credit (UAN: 0100-9999-15-086-B01-P).